Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
CME/CPD
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
CME/CPD
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 64, Issue 4
Oral antiviral therapy for HBeAg negative chronic hepatitis B: better stop or continue?
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Commentary
Oral antiviral therapy for HBeAg negative chronic hepatitis B: better stop or continue?
Online download statistics by month:
Online download statistics by month: August 2014 to August 2024
Abstract
Full
Pdf
Aug 2014
342
43
64
Sep 2014
98
22
37
Oct 2014
55
17
20
Nov 2014
52
6
8
Dec 2014
44
7
19
Jan 2015
36
2
3
Feb 2015
28
2
5
Mar 2015
830
53
164
Apr 2015
86
16
68
May 2015
58
10
27
Jun 2015
56
7
25
Jul 2015
38
2
12
Aug 2015
40
3
10
Sep 2015
34
7
12
Oct 2015
29
1
4
Nov 2015
41
7
11
Dec 2015
40
6
10
Jan 2016
38
3
8
Feb 2016
24
4
5
Mar 2016
36
4
7
Apr 2016
48
3
7
May 2016
33
0
4
Jun 2016
34
6
8
Jul 2016
28
2
4
Aug 2016
39
1
3
Sep 2016
61
6
8
Oct 2016
35
6
1
Nov 2016
36
9
3
Dec 2016
39
10
4
Jan 2017
42
10
5
Feb 2017
27
10
1
Mar 2017
24
3
0
Apr 2017
32
6
2
May 2017
36
3
2
Jun 2017
37
3
2
Jul 2017
41
5
7
Aug 2017
111
1
2
Sep 2017
83
1
2
Oct 2017
85
1
1
Nov 2017
62
1
1
Dec 2017
28
2
2
Jan 2018
58
1
0
Feb 2018
36
0
0
Mar 2018
96
3
0
Apr 2018
49
7
2
May 2018
54
1
1
Jun 2018
77
2
5
Jul 2018
33
1
0
Aug 2018
41
1
3
Sep 2018
25
1
1
Oct 2018
33
1
2
Nov 2018
82
1
1
Dec 2018
50
0
1
Jan 2019
138
2
4
Feb 2019
72
1
1
Mar 2019
62
1
2
Apr 2019
36
0
0
May 2019
53
4
1
Jun 2019
22
0
0
Jul 2019
35
5
3
Aug 2019
35
1
0
Sep 2019
35
0
0
Oct 2019
40
2
2
Nov 2019
48
2
3
Dec 2019
40
0
1
Jan 2020
40
0
0
Feb 2020
59
1
0
Mar 2020
41
0
0
Apr 2020
45
0
0
May 2020
26
0
0
Jun 2020
48
1
1
Jul 2020
42
0
0
Aug 2020
45
0
0
Sep 2020
54
0
0
Oct 2020
35
0
0
Nov 2020
52
0
0
Dec 2020
54
0
0
Jan 2021
41
0
0
Feb 2021
46
0
0
Mar 2021
45
1
1
Apr 2021
36
0
1
May 2021
20
0
0
Jun 2021
1
0
0
Jul 2021
15
0
0
Aug 2021
1
0
0
Oct 2021
10
0
1
Nov 2021
17
0
0
Dec 2021
26
0
0
Jan 2022
58
0
0
Feb 2022
20
1
1
Mar 2022
31
1
0
Apr 2022
23
0
0
May 2022
71
1
0
Jun 2022
69
1
0
Jul 2022
69
1
0
Aug 2022
43
0
0
Sep 2022
44
2
0
Oct 2022
40
2
0
Nov 2022
24
0
0
Dec 2022
16
0
0
Jan 2023
17
1
1
Feb 2023
78
1
0
Mar 2023
4
0
0
Apr 2023
5
1
1
May 2023
23
0
0
Jun 2023
18
0
0
Jul 2023
14
0
0
Aug 2023
12
0
0
Sep 2023
2
0
0
Oct 2023
33
2
0
Nov 2023
38
6
4
Dec 2023
42
1
0
Jan 2024
6
0
0
Feb 2024
8
0
0
Mar 2024
13
1
1
Apr 2024
23
1
1
May 2024
20
0
0
Jun 2024
18
0
0
Jul 2024
32
0
0
Aug 2024
29
4
0
Total
5958
378
634
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?